| scholarly article | Q13442814 |
| P2093 | author name string | M D Burdick | |
| R M Strieter | |||
| S L Kunkel | |||
| D A Arenberg | |||
| P J Polverini | |||
| R I Whyte | |||
| S B Morris | |||
| M D Iannettoni | |||
| M C Glass | |||
| D T Taub | |||
| P2860 | cites work | Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides | Q24298587 |
| Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines | Q71617497 | ||
| Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1 | Q71644976 | ||
| Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis | Q71692071 | ||
| Interleukln-8 stimulates angiogenesis in rats | Q72080099 | ||
| Human growth factor (huGRO), interleukin-8 (IL-8) and interferon-gamma-inducible protein (gamma-IP-10) gene expression in cultured normal human keratinocytes | Q72566035 | ||
| IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes | Q72901010 | ||
| Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins | Q24300179 | ||
| Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells | Q24306649 | ||
| Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo | Q24678892 | ||
| Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo | Q29614729 | ||
| Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma | Q29615947 | ||
| A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin | Q33763790 | ||
| Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis | Q34325744 | ||
| The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis | Q34662335 | ||
| Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines | Q35452938 | ||
| Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung | Q35817557 | ||
| Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines | Q35831110 | ||
| Expression of IP-10, a lipopolysaccharide- and interferon-gamma-inducible protein, in murine mesangial cells in culture | Q35832232 | ||
| Tumor dormancy in vivo by prevention of neovascularization | Q36271710 | ||
| Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon | Q36347669 | ||
| IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo | Q36362293 | ||
| Constitutive expression of interferon gamma-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes | Q36362922 | ||
| Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma | Q36363086 | ||
| The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation | Q36365144 | ||
| Regression of Experimental Iris Neovascularization with Systemic Alpha-interferon | Q36695100 | ||
| Properties of the novel proinflammatory supergene "intercrine" cytokine family. | Q37357898 | ||
| Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis | Q40377374 | ||
| Relation of vascular proliferation to tumor growth | Q40576314 | ||
| Basics of cutaneous wound repair | Q40834153 | ||
| Epidemiology and etiology of lung cancer. | Q40891468 | ||
| Distribution of integrin cell adhesion receptors on normal bronchial epithelial cells and lung cancer cells in vitro and in vivo | Q41080592 | ||
| Inhibition of wound healing in mice by local interferon alpha/beta injection | Q41163200 | ||
| The production of interleukin-1 receptor antagonist by human bronchogenic carcinoma | Q41529853 | ||
| Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: not an invariant correlation with metastasis | Q41602595 | ||
| In vivo and in vitro invasiveness of human lung carcinoma cell lines | Q41709094 | ||
| Interleukin-8. A corneal factor that induces neovascularization | Q42050315 | ||
| The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin | Q42209173 | ||
| Lymphotoxin, tumor necrosis factor, and gamma interferon are cytostatic for normal human keratinocytes | Q42490203 | ||
| Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. | Q43731881 | ||
| Interleukin-8 as a macrophage-derived mediator of angiogenesis | Q44053300 | ||
| Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking | Q44428809 | ||
| Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. | Q53516782 | ||
| Activated macrophages induce vascular proliferation | Q53988557 | ||
| Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. | Q54400192 | ||
| Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth | Q67544774 | ||
| Thiol-containing compounds inhibit the production of monocyte/macrophage-derived angiogenic activity | Q67713400 | ||
| Stimulation of neovascularization by human rheumatoid synovial tissue macrophages | Q68962580 | ||
| Potent and specific inhibition of IL-8-, IL-1 alpha- and IL-1 beta-induced in vitro human lymphocyte migration by calcium channel antagonists | Q69557318 | ||
| Inhibition of in vitro angiogenesis by lymphotoxin and interferon-gamma | Q70402069 | ||
| The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis | Q71603193 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | non-small-cell lung carcinoma | Q3658562 |
| P304 | page(s) | 981-992 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases | |
| P478 | volume | 184 |
| Q41275639 | A model for cancer-suppressive inflammation |
| Q24804035 | A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis |
| Q35914617 | A post-transcriptional pathway represses monocyte VEGF-A expression and angiogenic activity. |
| Q35158048 | A potential role for CXCR3 chemokines in the response to ocular HSV infection |
| Q48201872 | A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer |
| Q24303828 | An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 |
| Q35048828 | Analysis of the role of chemokines in angiogenesis. |
| Q81069451 | Antibody-cytokine fusion proteins: applications in cancer therapy |
| Q36980421 | Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine model |
| Q33713723 | Apoptosis and angiogenesis: an evolving mechanism for fibrosis |
| Q35753903 | Association between preeclampsia and the CXC chemokine family (Review). |
| Q38747771 | Atypical chemokine receptors in cancer: friends or foes? |
| Q28383941 | C-X-C ligand 10 and C-X-C receptor 3 status can predict tamoxifen treatment response in breast cancer patients |
| Q41911701 | CCL19 reduces tumour burden in a model of advanced lung cancer |
| Q81459070 | CD4+ T-cell-dependent tumour rejection in an immune-privileged environment requires macrophages |
| Q43654357 | CD8(+) T cells armed with retrovirally transduced IFN-gamma. |
| Q40724369 | CXC and CC chemokines as angiogenic modulators in nonhaematological tumors. |
| Q36944172 | CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells |
| Q36676660 | CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? |
| Q37341761 | CXCR2 and RET single nucleotide polymorphisms in pancreatic cancer |
| Q44305003 | CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10). |
| Q43843160 | CXCR3 expression in human central nervous system diseases. |
| Q30408881 | CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells |
| Q37217254 | Cancer as an overhealing wound: an old hypothesis revisited |
| Q24684115 | Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer |
| Q42028897 | Cellular and molecular requirements for rejection of B16 melanoma in the setting of regulatory T cell depletion and homeostatic proliferation |
| Q36474770 | Characterisation of SNP haplotype structure in chemokine and chemokine receptor genes using CEPH pedigrees and statistical estimation |
| Q35031912 | Chemokine biology in cancer. |
| Q34119846 | Chemokine expression patterns differ within anatomically distinct regions of the genital tract during Chlamydia trachomatis infection |
| Q33568187 | Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer |
| Q38040509 | Chemokine-based immunotherapy: delivery systems and combination therapies. |
| Q34798754 | Chemokines and cancer. |
| Q30426904 | Chemokines as mediators of angiogenesis. |
| Q30438032 | Chemokines as mediators of neovascularization |
| Q30427886 | Chemokines as mediators of tumor angiogenesis and neovascularization |
| Q34540743 | Chemokines in tumor angiogenesis and metastasis |
| Q37608615 | Chemokines in tumor-associated angiogenesis. |
| Q40614552 | Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. |
| Q40419683 | Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth. |
| Q36488894 | Clinical utilization of chemokines to combat cancer: the double-edged sword |
| Q47910612 | Cloning of DLM-1, a novel gene that is up-regulated in activated macrophages, using RNA differential display |
| Q45876491 | Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity |
| Q35870139 | Combining CXCL10 gene therapy and radiotherapy improved therapeutic efficacy in cervical cancer HeLa cell xenograft tumor models |
| Q35201488 | Comparison of human lung cancer/SCID mouse tumor xenografts and cell culture growth with patient clinical outcomes |
| Q79079447 | Concentrations of interferon-gamma-induced protein-10 (IP-10), an antiangiogenic substance, are decreased in peritoneal fluid of women with advanced endometriosis |
| Q35328903 | Critical role for CXC ligand 10/CXC receptor 3 signaling in the murine neonatal response to sepsis. |
| Q56966393 | Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients |
| Q49656814 | Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis? |
| Q53201799 | Discrimination of agonist and antagonist forms of CXCL10 in biological samples. |
| Q35786924 | Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells |
| Q42359630 | Distinct immunological activation profiles of dSLIM® and ProMune® depend on their different structural context |
| Q35855285 | Diversity of the angiogenic phenotype in non-small cell lung cancer |
| Q40071671 | Downregulation of IFN-gammaR in association with loss of Fas function is linked to tumor progression |
| Q37932437 | Dual biological effects of the cytokines interleukin-10 and interferon-γ. |
| Q46319754 | ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis |
| Q36276014 | Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide |
| Q33939602 | Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes |
| Q37384020 | Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer |
| Q36715205 | Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy |
| Q35543779 | Fine Tuning the Transcriptional Regulation of the CXCL1 Chemokine |
| Q37175083 | G-protein coupled chemoattractant receptors and cancer |
| Q38942567 | Gallium maltolate inhibits human cutaneous T-cell lymphoma tumor development in mice |
| Q42209151 | Genuine Immunomodulation With dSLIM. |
| Q39243093 | Heparins modulate the IFN-γ-induced production of chemokines in human breast cancer cells |
| Q22009509 | Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3) |
| Q36710977 | Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity |
| Q33370417 | IFN-gamma impairs release of IL-8 by IL-1beta-stimulated A549 lung carcinoma cells |
| Q91267128 | IL-10 promotes malignant pleural effusion in mice by regulating TH 1- and TH 17-cell differentiation and migration |
| Q43638697 | IL-12 attenuates bleomycin-induced pulmonary fibrosis |
| Q24305068 | IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain |
| Q36413804 | Immunotoxic effects of thymus in mice following exposure to nanoparticulate TiO2. |
| Q48478595 | Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma |
| Q50051034 | Improving immune-vascular crosstalk for cancer immunotherapy. |
| Q73844814 | In vitro and in vivo systems to assess role of C-X-C chemokines in regulation of angiogenesis |
| Q35745538 | In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue |
| Q28203416 | In vivo stability of human chemokine and chemokine receptor expression |
| Q46601343 | Increased expression of chemokine KC, an interleukin-8 homologue, in a model of oxygen-induced retinopathy |
| Q35560305 | Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis |
| Q34769124 | Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer |
| Q41471150 | Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer |
| Q73141291 | Inhibition by vasoactive intestinal polypeptide (VIP) of angiogenesis induced by murine Colon 26-L5 carcinoma cells metastasized in liver |
| Q36334094 | Inositol 1, 4, 5-trisphosphate-dependent nuclear calcium signals regulate angiogenesis and cell motility in triple negative breast cancer |
| Q78951915 | Interaction of monocytes with vascular endothelial cells synergistically induces interferon gamma-inducible protein 10 expression through activation of specific cell surface molecules and cytokines |
| Q43085842 | Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis |
| Q34372146 | Interferon-β inhibits glioma angiogenesis through downregulation of vascular endothelial growth factor and upregulation of interferon inducible protein 10. |
| Q34646946 | Interleukin-7 Gene-Modified Dendritic Cells Reduce Pulmonary Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma |
| Q40847197 | Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10. |
| Q54264754 | Investigation of the expression of mediators of neovascularization from mononuclear leukocytes in thromboangiitis obliterans. |
| Q42087882 | Involvement of endothelial PECAM-1/CD31 in angiogenesis. |
| Q36019493 | Knockdown of aberrantly expressed nuclear localized decorin attenuates tumour angiogenesis related mediators in oral cancer progression model in vitro. |
| Q51369594 | Lung inflammation caused by long-term exposure to titanium dioxide in mice involving in NF-κB signaling pathway. |
| Q34268934 | Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair |
| Q28249954 | Molecular cloning and functional characterization of a novel CC chemokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lymphocytes |
| Q92479800 | Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review |
| Q33793308 | Molecular pathogenesis of lung cancer |
| Q80961223 | Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis |
| Q27001081 | Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses |
| Q58071166 | Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ |
| Q36958177 | One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment |
| Q24804267 | Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis |
| Q64964168 | PAQR4 promotes cell proliferation and metastasis through the CDK4-pRB-E2F1 pathway in non-small-cell lung cancer. |
| Q37705023 | Platelet-derived chemokines: pathophysiology and therapeutic aspects |
| Q39604493 | Pleural fluid mononuclear cells (PFMCs) from tuberculous pleurisy can migrate in vitro in response to CXCL10. |
| Q33900573 | Potent Therapeutic Activity Against Peritoneal Dissemination and Malignant Ascites by the Novel Anti-Folate Receptor Alpha Antibody KHK2805. |
| Q53431081 | Progress in understanding the molecular pathogenesis of human lung cancer. |
| Q77154358 | Pulmonary metastasis |
| Q37900430 | Regulation of angiostatic chemokines driven by IL-12 and IL-27 in human tumors |
| Q55477373 | Regulation of human IP-10 gene expression in astrocytoma cells by inflammatory cytokines. |
| Q34397096 | Regulation of tumor growth by IFN-gamma in cancer immunotherapy. |
| Q34205907 | Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signaling. |
| Q37379547 | Review paper: the role of inflammation in mouse pulmonary neoplasia |
| Q24805285 | Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy |
| Q34724089 | Role of CXCL1 in tumorigenesis of melanoma. |
| Q30426606 | Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer |
| Q26796395 | Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation |
| Q24797335 | SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10 |
| Q89147033 | Salivary cytokine panel indicative of non-small cell lung cancer |
| Q77996264 | Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells |
| Q38964255 | Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model |
| Q35131138 | Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis |
| Q37728270 | Sulfated tyrosines 27 and 29 in the N-terminus of human CXCR3 participate in binding native IP-10. |
| Q40737184 | Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice |
| Q40038001 | Synergistic antitumor effect of CXCL10 with hyperthermia |
| Q62019424 | TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma |
| Q36172008 | The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3 |
| Q92879880 | The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment |
| Q51072169 | The Inflammatory CXC Chemokines, GROαhigh, IP-10low, and MIGlow, in Tumor Microenvironment Can Be Used as New Indicators for Non-small Cell Lung Cancer Progression. |
| Q37156706 | The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan |
| Q47384264 | The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10. |
| Q41716944 | The molecular and cellular biology of the chemokines |
| Q84975992 | The parallel lives of angiogenesis and immunosuppression: cancer and other tales |
| Q24811681 | The response of VEGF-stimulated endothelial cells to angiostatic molecules is substrate-dependent |
| Q38023245 | The role of CXC chemokines and their receptors in the progression and treatment of tumors |
| Q47772542 | The role of CXC chemokines in the regulation of angiogenesis in association with lung cancer |
| Q34385436 | The role of CXC chemokines in the regulation of tumor angiogenesis |
| Q38238738 | The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis. |
| Q28207895 | The roles of IFN gamma in protection against tumor development and cancer immunoediting |
| Q43671920 | The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases |
| Q47671475 | Tumor angiogenesis is regulated by CXC chemokines |
| Q41904511 | Tumor-induced senescent T cells promote the secretion of pro-inflammatory cytokines and angiogenic factors by human monocytes/macrophages through a mechanism that involves Tim-3 and CD40L. |
| Q33926235 | Two different homing pathways involving integrin β7 and E-selectin significantly influence trafficking of CD4 cells to the genital tract following Chlamydia muridarum infection |
Search more.